Leopoldina Hospital Schweinfurt, Department of Radiotherapy and Radiation Oncology
Schweinfurt, Bavaria, 97421, Germany
NCT Number: NCT04574323
The study aims to test the feasibility and effects of a dietary and physical activity intervention based on evolutionary considerations in an oncological setting.
Looking for future studies?
Notify Me18 year–75 year
Female
Interventional
Not applicable
Schweinfurt, Bavaria, 97421, Germany
A total of 13 breast cancer patients referred to our clinic for curative radiotherapy were recruited for this pilot study. The women were supposed to undertake a "Paleolithic lifestyle" (PL) intervention consisting of a Paleolithic diet and daily outdoor activity of at least 30 min duration while undergoing radiotherapy. Body composition was measured weekly by bioimpedance analysis. Blood parameters were assessed before, during, and at the end of radiotherapy. A control group on an unspecified standard diet (SD) was assigned by propensity score matching.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard curative radiotherapy
This intervention consists of daily outdoor walks or bike rides of at least 30 min duration, preferably done at noon to maximize vitamin D production, and the adoption of a Paleolithic diet. For the outdoor activity, patients were told to not use sun screen. The Paleolithic diet prescription emphasized the consumption of fatty meats and organ meats from humanely raised animals, wild-caught fish, eggs, nuts and seeds, algae, spices, vegetables and fruits. Excluded were processed foods, grains of all types, legumes, vegetable oils except for native coconut and olive oil and dairy products except for ghee. No dietary supplements were allowed.
Time frame: through study completion, an average of 5 weeks
Used to measure feasibility. The intervention is rated as feasible if dropout rate is <30%
Time frame: through study completion, an average of 5 weeks
Measured on a bioimpedance scale (seca mBCA, seca Deutschland, Hamburg, Germany)
Time frame: through study completion, an average of 5 weeks
Difference between final (average 5 weekks) and baseline 25-hydroxyvitamin D level
Time frame: through study completion, an average of 5 weeks
Change between baseline and final (average 5 weeks) beta-hydroxybutyrate levels
MVZ Leopoldina GmbH
Other
Short-term Effects of a Paleolithic Lifestyle Intervention in Breast Cancer Patients Undergoing Radiotherapy: A Pilot and Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04980118
Body Weight, Body Weight Changes
Madrid, Spain
View Trial DetailsNCT02009449
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT06096623
Breast Cancer, Breast Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05708950
Adnexal Diseases, Breast Cancer
Santa Monica, California, United States
View Trial Details